Peterson Neil 4
4 · MERIT MEDICAL SYSTEMS INC · Filed Apr 2, 2025
Insider Transaction Report
Form 4
Peterson Neil W.
CHIEF OPERATING OFFICER
Transactions
- Exercise/Conversion
Non-qualified stock options (right to buy)
2025-04-01−5,000→ 5,000 totalExercise: $54.40From: 2020-04-25Exp: 2026-04-25→ Common Stock (10,000 underlying) - Exercise/Conversion
Common Stock, No Par Value
2025-04-01$54.40/sh+5,000$272,000→ 33,369 total - Sale
Common Stock, No Par Value
2025-04-01$104.53/sh−5,000$522,650→ 28,369 total
Holdings
- 25,000
Non-qualified stock options (right to buy)
Exercise: $68.33From: 2022-08-19Exp: 2028-08-19→ Common Stock (25,000 underlying) - 13,576
Non-qualified stock options (right to buy)
Exercise: $70.58From: 2024-02-28Exp: 2030-02-28→ Common Stock (13,576 underlying)
Footnotes (5)
- [F1]The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 6, 2024.
- [F2]The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $103.63 to $105.36, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
- [F3]Becomes exercisable in equal annual installments of 20% commencing 04/25/2020.
- [F4]Becomes exercisable in equal annual installments of 25% commencing 08/19/2022.
- [F5]Becomes exercisable in equal annual installments of 25% commencing 2/28/2024.